NAD+ Therapy: What It Is, Cost, and What the Evidence Actually Shows

Biology

What NAD+ Is and What It Does

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every cell, central to converting nutrients into ATP and to the activity of enzymes that regulate DNA repair, inflammation, and cellular stress response (notably sirtuins and PARPs).

NAD+ levels decline measurably with age. That decline correlates with the decline in mitochondrial function, metabolic flexibility, and DNA-repair capacity that defines biological aging. The clinical question is whether restoring NAD+ via supplementation changes meaningful outcomes — and that is where the evidence becomes thinner than the marketing.

Delivery

Delivery Methods: IV, Injection, Oral Precursors

• ·IV NAD+ infusions. 250–1000 mg over several hours, often delivered as a series. Bypasses oral absorption but is the most expensive and time-intensive route. Direct NAD+ infusion is also poorly tolerated at speed — patients experience chest pressure, flushing, and abdominal cramping if pushed too fast.
• ·Subcutaneous or intramuscular NAD+ injections. Smaller doses, more frequent. Cheaper than IV; less data on bioavailability.
• ·Oral precursors — NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). Convert to NAD+ in the body. Best-studied oral pathway, with measurable increases in blood NAD+ at typical doses (250–1000 mg/day).

Whether IV NAD+ itself crosses cell membranes intact, or whether the benefit comes from breakdown products and precursors, remains debated in the literature.

Evidence

What Clinics Claim vs. What Studies Show

Claims commonly marketed: more energy, mental clarity, athletic recovery, jet-lag mitigation, slower aging, hangover recovery, addiction-withdrawal support.

What human evidence actually supports: NR and NMN raise blood NAD+ levels reliably; short-term safety appears good at studied doses; signals exist for improved insulin sensitivity and modest cardiovascular markers in some trials. Longevity outcomes — actual extension of healthspan or lifespan in humans — have not been demonstrated.

The strongest specific-indication evidence is in neurodegenerative and metabolic disease contexts (Parkinson's, mitochondrial disorders, certain cardiometabolic conditions) where targeted trials are ongoing. General “anti-aging” use is a reasonable hypothesis backed by mechanistic biology, not by outcome data.

Cost

What NAD+ Therapy Costs in 2026

• ·IV NAD+ infusions: typically $300–$1,000 per session in concierge and longevity clinics; full induction series of 6–10 sessions runs $2,000–$8,000.
• ·NAD+ injections: $50–$150 per shot; weekly or twice-weekly programs $200–$600/month.
• ·Oral NMN: $40–$120/month for clinical-grade product at 500–1000 mg/day.
• ·Oral NR (Niagen and similar branded forms): $40–$80/month.

Insurance does not cover NAD+ therapy for general wellness, longevity, or anti-aging indications.

Safety

Safety and Side Effects

Short-term safety in healthy adults appears good for both oral precursors and supervised IV/injection routes. Reported issues:

• ·IV: chest tightness, nausea, flushing, abdominal cramping — usually rate-related and resolved by slowing the infusion.
• ·Oral NMN/NR: generally well tolerated; rare GI upset.
• ·Open questions: long-term effects of sustained high NAD+ on cellular pathways including those relevant to cancer biology have not been fully characterized in humans.

The honest take

The Physician's Honest Take

NAD+ therapy sits in the category of well-tolerated, biologically plausible, evidence-thin interventions. A physician who tells you it will reverse aging is overstating; a physician who tells you it is useless is also overstating.

Reasonable use looks like this: oral NMN or NR as part of a broader longevity program, paired with sleep, training, nutrition, and metabolic optimization — not as a standalone treatment, and not as a substitute for the interventions with stronger evidence (resistance training, sleep, Mediterranean-pattern nutrition, treatment of cardiometabolic disease).